Centre for Biological Research Margarita Salas - CSIC
If you are the contact person for this centre and you wish to make any changes, please contact us.
Head of the Experimental Pharmacology and New Targets in Cardiopulmonary Disorders Group at the Margarita Salas Biological Research Centre - CSIC
Researcher in the Viral Immunology: Therapies and Vaccines group at the Margarita Salas Biological Research Center.
Senior scientist at the Margarita Salas Biological Research Centre of the CSIC.
The European Centre for Disease Prevention and Control (ECDC) reported that on January 29th, Spanish authorities notified a possible case of human infection with swine flu virus A(H1N1)v in a worker from a Catalan pig farm. After being diagnosed with bronchitis, subsequent laboratory analyses confirmed it as swine flu A(H1N1)v. The ECDC informs that the patient has fully recovered, and to date, no new cases have been detected among close contacts or among the worker's colleagues at the farm.
Research published in The BMJ has compared the information on cancer drugs available to regulatory authorities with that officially received by doctors and patients. According to the authors, important information is often omitted. In particular, "none of the package inserts communicated information about the benefits of the drug that patients could expect based on the results of the studies". In addition, doubts raised by European evaluators about the reliability of the evidence "were rarely communicated to physicians, patients or the public," they say.
A paper published today in the journal Circulation concludes that acute myocarditis is a rare complication in patients hospitalised with covid-19 and that the severity of its prognosis depends on the simultaneous presence of pneumonia.